| 1 | Cyclosporine Treatment in Patients with Kawasaki Disease and Coronary Artery Aneurysms or Treatment Resistance | 1.7 | 11 | Citations (PDF) |
| 2 | A genetically modulated Toll-like receptor-tolerant phenotype in peripheral blood cells of children with multisystem inflammatory syndrome | 0.8 | 7 | Citations (PDF) |
| 3 | Age-Dependent Variations in Kawasaki Disease Incidence in Japan | 5.2 | 24 | Citations (PDF) |
| 4 | The etiologies of Kawasaki disease | 6.8 | 84 | Citations (PDF) |
| 5 | A Thrombolytic Protocol of Bivalirudin for Giant Coronary Artery Aneurysms and Thrombosis in Kawasaki Disease | 1.7 | 1 | Citations (PDF) |
| 6 | Plasma cell-free RNA signatures of inflammatory syndromes in children | 5.3 | 23 | Citations (PDF) |
| 7 | Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C) | 5.9 | 13 | Citations (PDF) |
| 8 | EVALUATION OF THE 2017 AHA INCOMPLETE KD DIAGNOSTIC ALGORITHM AND AN EVIDENCE-BASED PROPOSAL OF CHANGES | 1.5 | 0 | Citations (PDF) |
| 9 | Multisystem Inflammatory Syndrome therapies in children (MISTIC): A randomized trial | 0.9 | 7 | Citations (PDF) |
| 10 | Intravenous immunoglobulin resistance in Kawasaki disease patients: prediction using clinical data | 1.5 | 27 | Citations (PDF) |
| 11 | Predictors of Myocardial Ischemia in Patients with Kawasaki Disease: Insights from Patient-Specific Simulations of Coronary Hemodynamics | 1.3 | 15 | Citations (PDF) |
| 12 | Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis | 1.4 | 34 | Citations (PDF) |
| 13 | Endothelial Cell Response in Kawasaki Disease and Multisystem Inflammatory Syndrome in Children | 3.2 | 9 | Citations (PDF) |
| 14 | Coronary Sinus Thrombosis and Post-Myocardial Infarction Syndrome in Kawasaki Disease | 0.2 | 2 | Citations (PDF) |
| 15 | DOACs in Patients With Giant Coronary Artery Aneurysms After Kawasaki Disease | 5.2 | 24 | Citations (PDF) |
| 16 | SARS-CoV-2 variants are associated with different clinical courses in children with MIS-C | 2.2 | 2 | Citations (PDF) |
| 17 | Characterization of SARS‐CoV‐2 and common cold coronavirus‐specific T‐cell responses in MIS‐C and Kawasaki disease children | 2.4 | 18 | Citations (PDF) |
| 18 | Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C | 3.3 | 34 | Citations (PDF) |
| 19 | Anakinra Treatment in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysms: A Phase I/IIa Trial | 1.7 | 52 | Citations (PDF) |
| 20 | Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron and Other Variants in Serum From Children With Vaccination-Induced Myocarditis | 3.8 | 0 | Citations (PDF) |
| 21 | Intravenous immunoglobulin induces IgG internalization by tolerogenic myeloid dendritic cells that secrete IL-10 and expand Fc-specific regulatory T cells | 2.3 | 20 | Citations (PDF) |
| 22 | Long-term health outcomes in young adults after Kawasaki disease | 0.6 | 4 | Citations (PDF) |
| 23 | An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease | 11.0 | 77 | Citations (PDF) |
| 24 | Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C | 11.0 | 45 | Citations (PDF) |
| 25 | T Cells in Multisystem Inflammatory Syndrome in Children (MIS-C) Have a Predominant CD4+ T Helper Response to SARS-CoV-2 Peptides and Numerous Virus-Specific CD4− CD8− Double-Negative T Cells | 3.2 | 20 | Citations (PDF) |
| 26 | RNA Sequencing Reveals Beneficial Effects of Atorvastatin on Endothelial Cells in Acute Kawasaki Disease | 3.1 | 16 | Citations (PDF) |
| 27 | Single center blind testing of a US multi-center validated diagnostic algorithm for Kawasaki disease in Taiwan | 3.3 | 5 | Citations (PDF) |
| 28 | Exercise Stress Echocardiography in Kawasaki Disease Patients with Coronary Aneurysms | 0.5 | 18 | Citations (PDF) |
| 29 | Temporal Clusters of Kawasaki Disease Cases Share Distinct Phenotypes That Suggest Response to Diverse Triggers | 1.7 | 16 | Citations (PDF) |
| 30 | Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children | 13.1 | 280 | Citations (PDF) |
| 31 | Comparison Between Currently Recommended Long-Term Medical Management of Coronary Artery Aneurysms After Kawasaki Disease and Actual Reported Management in the Last Two Decades | 0.5 | 7 | Citations (PDF) |
| 32 | Characterization of the T Cell Response to Lactobacillus casei Cell Wall Extract in Children With Kawasaki Disease and Its Potential Role in Vascular Inflammation | 1.1 | 5 | Citations (PDF) |
| 33 | Identification of novel locus associated with coronary artery aneurysms and validation of loci for susceptibility to Kawasaki disease | 2.1 | 34 | Citations (PDF) |
| 34 | Kawasaki Disease Patient Stratification and Pathway Analysis Based on Host Transcriptomic and Proteomic Profiles | 3.2 | 18 | Citations (PDF) |
| 35 | Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C | 6.8 | 64 | Citations (PDF) |
| 36 | Computational modeling of blood component transport related to coronary artery thrombosis in Kawasaki disease | 1.9 | 20 | Citations (PDF) |
| 37 | Inflammasome Activation in Children With Kawasaki Disease and Multisystem Inflammatory Syndrome | 4.3 | 22 | Citations (PDF) |
| 38 | Biomarkers of inflammation and fibrosis in young adults with history of Kawasaki disease | 0.6 | 6 | Citations (PDF) |
| 39 | Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial | 3.9 | 106 | Citations (PDF) |
| 40 | Temporal clustering of Kawasaki disease cases around the world | 2.7 | 15 | Citations (PDF) |
| 41 | Global epidemiology of vasculitis | 17.1 | 319 | Citations (PDF) |
| 42 | Biomarkers of Inflammation and Fibrosis in Kawasaki Disease Patients Years After Initial Presentation With Low Ejection Fraction | 3.1 | 17 | Citations (PDF) |
| 43 | Biomarkers for the Discrimination of Acute Kawasaki Disease From Infections in Childhood | 1.1 | 23 | Citations (PDF) |
| 44 | Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemic | 1.7 | 92 | Citations (PDF) |
| 45 | Multicentre validation of a computer-based tool for differentiation of acute Kawasaki disease from clinically similar febrile illnesses | 1.4 | 14 | Citations (PDF) |
| 46 | High-Throughput Screening of Kawasaki Disease Sera for Antiviral Antibodies | 2.2 | 14 | Citations (PDF) |
| 47 | Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 | 15.8 | 1,739 | Citations (PDF) |
| 48 | Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis | 3.1 | 83 | Citations (PDF) |
| 49 | Phase I/IIa Trial of Atorvastatin in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysm | 1.7 | 34 | Citations (PDF) |
| 50 | Hemodynamic variables in aneurysms are associated with thrombotic risk in children with Kawasaki disease | 1.6 | 68 | Citations (PDF) |
| 51 | Cyclosporine and coronary outcomes in Kawasaki disease | 1.7 | 3 | Citations (PDF) |
| 52 | Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population | 3.1 | 114 | Citations (PDF) |
| 53 | Extensive Ethnic Variation and Linkage Disequilibrium at the FCGR2/3 Locus: Different Genetic Associations Revealed in Kawasaki Disease | 3.3 | 57 | Citations (PDF) |
| 54 | Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis | 2.9 | 92 | Citations (PDF) |
| 55 | The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease | 1.1 | 22 | Citations (PDF) |
| 56 | Bifid T waves on the ECG and genetic variation in
calcium channel voltage‐dependent beta 2 subunit
gene (
CACNB2
) in acute Kawasaki disease | 0.0 | 3 | Citations (PDF) |
| 57 | Infliximab Pharmacokinetics are Influenced by Intravenous Immunoglobulin Administration in Patients with Kawasaki Disease | 2.1 | 27 | Citations (PDF) |
| 58 | Pediatric tolerogenic DCs expressing CD4 and immunoglobulin‐like transcript receptor (ILT)‐4 secrete IL‐10 in response to Fc and adenosine | 2.4 | 20 | Citations (PDF) |
| 59 | Computed Tomography Coronary Angiography for Evaluation of Children With Kawasaki Disease | 0.8 | 34 | Citations (PDF) |
| 60 | History of the worldwide emergence of Kawasaki disease | 0.7 | 22 | Citations (PDF) |
| 61 | Clustering and climate associations of Kawasaki Disease in San Diego County suggest environmental triggers | 2.7 | 40 | Citations (PDF) |
| 62 | How Should We Classify Kawasaki Disease? | 3.3 | 63 | Citations (PDF) |
| 63 | Kawasaki Disease Outcomes and Response to Therapy in a Multiethnic Community: A 10-Year Experience | 1.7 | 74 | Citations (PDF) |
| 64 | Association of Initially Normal Coronary Arteries With Normal Findings on Follow-up Echocardiography in Patients With Kawasaki Disease | 4.6 | 31 | Citations (PDF) |
| 65 | New insights into cardiovascular disease in patients with Kawasaki disease | 1.4 | 5 | Citations (PDF) |
| 66 | Diagnosis of Kawasaki Disease Using a Minimal Whole-Blood Gene Expression Signature | 4.6 | 122 | Citations (PDF) |
| 67 | Whole blood transcriptional profiles as a prognostic tool in complete and incomplete Kawasaki Disease | 1.5 | 59 | Citations (PDF) |
| 68 | Extreme giant aneurysms of three coronary arteries causing heart failure as late sequelae of Kawasaki disease | 2.6 | 1 | Citations (PDF) |
| 69 | PRINCESS: Privacy-protecting Rare disease International Network Collaboration via Encryption through Software guard extensionS | 3.2 | 89 | Citations (PDF) |
| 70 | Usefulness of Calcium Scoring as a Screening Examination in Patients With a History of Kawasaki Disease | 1.5 | 30 | Citations (PDF) |
| 71 | High Risk of Coronary Artery Aneurysms in Infants Younger than 6 Months of Age with Kawasaki Disease | 1.7 | 157 | Citations (PDF) |
| 72 | Assessment of Coronary Artery Aneurysms Caused by Kawasaki Disease Using Transluminal Attenuation Gradient Analysis of Computerized Tomography Angiograms | 1.5 | 13 | Citations (PDF) |
| 73 | Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | 13.1 | 3,415 | Citations (PDF) |
| 74 | miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition | 8.6 | 120 | Citations (PDF) |
| 75 | Urotensin 2 in Kawasaki disease pathogenesis | 1.5 | 5 | Citations (PDF) |
| 76 | Review: Found in Translation: International Initiatives Pursuing Interleukin‐1 Blockade for Treatment of Acute Kawasaki Disease | 4.7 | 68 | Citations (PDF) |
| 77 | Unbiased Screening of Kawasaki Disease Sera for Viral Antigen Exposure | 0.7 | 1 | Citations (PDF) |
| 78 | Whole genome sequencing of an African American family highlights toll like receptor 6 variants in Kawasaki disease susceptibility | 1.5 | 18 | Citations (PDF) |
| 79 | Urinary Colorimetric Sensor Array and Algorithm to Distinguish Kawasaki Disease from Other Febrile Illnesses | 1.5 | 4 | Citations (PDF) |
| 80 | Kawasaki Disease | 0.7 | 573 | Citations (PDF) |
| 81 | Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial) | 1.1 | 69 | Citations (PDF) |
| 82 | Letter by Daniels and Burns Regarding Article, “Incidence, Cause, and Comparative Frequency of Sudden Cardiac Death in National Collegiate Athletic Association Athletes: A Decade in Review” | 13.1 | 0 | Citations (PDF) |
| 83 | The Spectrum of Cardiovascular Lesions Requiring Intervention in Adults After Kawasaki Disease | 1.9 | 103 | Citations (PDF) |
| 84 | Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children | 1.2 | 27 | Citations (PDF) |
| 85 | Diagnostic Test Accuracy of a 2-Transcript Host RNA Signature for Discriminating Bacterial vs Viral Infection in Febrile Children | 15.8 | 335 | Citations (PDF) |
| 86 | Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population | 3.1 | 256 | Citations (PDF) |
| 87 | A Classification Tool for Differentiation of Kawasaki Disease from Other Febrile Illnesses | 1.7 | 30 | Citations (PDF) |
| 88 | Building a Natural Language Processing Tool to Identify Patients With High Clinical Suspicion for Kawasaki Disease from Emergency Department Notes | 1.2 | 50 | Citations (PDF) |
| 89 | Psoriasiform eruptions during Kawasaki disease (KD): A distinct phenotype | 1.6 | 33 | Citations (PDF) |
| 90 | A Novel Truncated Form of Serum Amyloid A in Kawasaki Disease | 1.5 | 12 | Citations (PDF) |
| 91 | Patterns of Fever in Children After Primary Treatment for Kawasaki Disease | 0.8 | 21 | Citations (PDF) |
| 92 | Acute Myocardial Ischemia in Adults Secondary to Missed Kawasaki Disease in Childhood | 1.5 | 60 | Citations (PDF) |
| 93 | Novel data-mining approach identifies biomarkers for diagnosis of Kawasaki disease | 1.5 | 26 | Citations (PDF) |
| 94 | Galectin-3 is a marker of myocardial and vascular fibrosis in Kawasaki disease patients with giant aneurysms | 1.6 | 34 | Citations (PDF) |
| 95 | The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease | 2.3 | 119 | Citations (PDF) |
| 96 | Fine specificities of natural regulatory T cells after IVIG therapy in patients with Kawasaki disease | 2.5 | 28 | Citations (PDF) |
| 97 | Cardiovascular pathology in 2 young adults with sudden, unexpected death due to coronary aneurysms from Kawasaki disease in childhood | 1.2 | 44 | Citations (PDF) |
| 98 | Role of TGF-β Signaling in Remodeling of Noncoronary Artery Aneurysms in Kawasaki Disease | 0.8 | 26 | Citations (PDF) |
| 99 | Pulmonary Artery Dilation and Right Ventricular Function in Acute Kawasaki Disease | 0.5 | 7 | Citations (PDF) |
| 100 | 118Transcriptional Profiling Discriminates Complete and Incomplete Kawasaki Disease (KD) from Adenovirus infection (HAdV) | 0.7 | 0 | Citations (PDF) |
| 101 | Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease | 5.9 | 164 | Citations (PDF) |
| 102 | Specificity of regulatory T cells that modulate vascular inflammation | 2.5 | 57 | Citations (PDF) |
| 103 | In Vitro Validation of Patient-Specific Hemodynamic Simulations in Coronary Aneurysms Caused by Kawasaki Disease | 1.5 | 39 | Citations (PDF) |
| 104 | Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan | 5.3 | 201 | Citations (PDF) |
| 105 | The long noncoding RNA
THRIL
regulates TNFα expression through its interaction with hnRNPL | 5.3 | 609 | Citations (PDF) |
| 106 | Thrombotic risk stratification using computational modeling in patients with coronary artery aneurysms following Kawasaki disease | 1.7 | 68 | Citations (PDF) |
| 107 | Lipoprotein Particle Concentrations in Children and Adults following Kawasaki Disease | 1.7 | 21 | Citations (PDF) |
| 108 | Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial | 45.2 | 283 | Citations (PDF) |
| 109 | Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease | 5.9 | 1 | Citations (PDF) |
| 110 | Lymph-Node-First Presentation of Kawasaki Disease Compared with Bacterial Cervical Adenitis and Typical Kawasaki Disease | 1.7 | 103 | Citations (PDF) |
| 111 | Point-of-Care Differentiation of Kawasaki Disease from Other Febrile Illnesses | 1.7 | 38 | Citations (PDF) |
| 112 | The role of TGF-β and myofibroblasts in the arteritis of Kawasaki disease | 1.7 | 89 | Citations (PDF) |
| 113 | Kawasaki disease and ENSO‐driven wind circulation | 2.9 | 20 | Citations (PDF) |
| 114 | Letter by Daniels et al Regarding Article, “Incidence, Causes, and Survival Trends From Cardiovascular-Related Sudden Cardiac Arrest in Children and Young Adults 0 to 35 Years of Age” | 13.1 | 0 | Citations (PDF) |
| 115 | A Simple Method for Assessment of Human Anti-Neu5Gc Antibodies Applied to Kawasaki Disease | 1.5 | 64 | Citations (PDF) |
| 116 | Seasonality of Kawasaki Disease: A Global Perspective | 1.5 | 176 | Citations (PDF) |
| 117 | Prolonged urticaria and fever in a toddler | 1.1 | 3 | Citations (PDF) |
| 118 | Calcineurin Inhibitor Treatment of Intravenous Immunoglobulin–Resistant Kawasaki Disease | 1.7 | 119 | Citations (PDF) |
| 119 | Calcium Scoring in Patients With a History of Kawasaki Disease | 3.9 | 41 | Citations (PDF) |
| 120 | Evolution of Laboratory Values in Patients With Kawasaki Disease | 0.8 | 110 | Citations (PDF) |
| 121 | Infliximab for Intravenous Immunoglobulin Resistance in Kawasaki Disease: A Retrospective Study | 1.7 | 182 | Citations (PDF) |
| 122 | Is Kawasaki disease incidence rising in Chandigarh, North India? | 1.4 | 82 | Citations (PDF) |
| 123 | Association of Kawasaki disease with tropospheric wind patterns | 2.7 | 170 | Citations (PDF) |
| 124 | Image-based modeling of hemodynamics in coronary artery aneurysms caused by Kawasaki disease | 1.7 | 97 | Citations (PDF) |
| 125 | Low Plasma d-Dimer Concentration Predicts the Absence of Traumatic Brain Injury in Children | 2.1 | 31 | Citations (PDF) |
| 126 | Endoplasmic reticulum stress drives a regulatory phenotype in human T-cell clones | 1.5 | 36 | Citations (PDF) |
| 127 | Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease | 1.3 | 45 | Citations (PDF) |
| 128 | Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance | 0.5 | 95 | Citations (PDF) |
| 129 | Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease | 2.5 | 72 | Citations (PDF) |
| 130 | Kawasaki Disease in India: Increasing Awareness or Increased Incidence? | 0.2 | 23 | Citations (PDF) |
| 131 | Gene Transcript Abundance Profiles Distinguish Kawasaki Disease from Adenovirus Infection | 2.2 | 50 | Citations (PDF) |
| 132 | Recognition of a Kawasaki Disease Shock Syndrome | 2.9 | 376 | Citations (PDF) |
| 133 | When Children With Kawasaki Disease Grow Up | 0.7 | 259 | Citations (PDF) |
| 134 | Resistance to Intravenous Immunoglobulin in Children with Kawasaki Disease | 1.7 | 397 | Citations (PDF) |
| 135 | Spatial and Temporal Clustering of Kawasaki Syndrome Cases | 0.8 | 68 | Citations (PDF) |
| 136 | The Riddle of Kawasaki Disease | 19.4 | 73 | Citations (PDF) |
| 137 | Delayed Diagnosis by Physicians Contributes to the Development of Coronary Artery Aneurysms in Children With Kawasaki Syndrome | 0.8 | 88 | Citations (PDF) |
| 138 | Gene-expression patterns reveal underlying biological processes in Kawasaki disease | 4.8 | 98 | Citations (PDF) |
| 139 | Pulsed corticosteroids of no benefit in Kawasaki disease | 1.7 | 2 | Citations (PDF) |
| 140 | Noninvasive Determination of Endothelial Cell Function in the Microcirculation in Kawasaki Syndrome | 0.5 | 11 | Citations (PDF) |
| 141 | Quantitation of Adenovirus Genome During Acute Infection in Normal Children | 0.8 | 34 | Citations (PDF) |
| 142 | Familial Occurrence of Kawasaki Syndrome in North America | 3.8 | 81 | Citations (PDF) |
| 143 | Genetic Variations in the Receptor‐Ligand PairCCR5andCCL3L1Are Important Determinants of Susceptibility to Kawasaki Disease | 2.2 | 103 | Citations (PDF) |
| 144 | Kawasaki Disease and Human Coronavirus | 2.2 | 52 | Citations (PDF) |
| 145 | Seasonality and Temporal Clustering of Kawasaki Syndrome | 2.0 | 176 | Citations (PDF) |
| 146 | Infliximab treatment for refractory Kawasaki syndrome | 1.7 | 261 | Citations (PDF) |
| 147 | The Narratives of Kawasaki Disease | 0.0 | 17 | Citations (PDF) |
| 148 | The histories of Kawasaki disease | 0.2 | 4 | Citations (PDF) |
| 149 | Organization and expression analysis of the zebrafish hepcidin gene, an antimicrobial peptide gene conserved among vertebrates | 1.3 | 152 | Citations (PDF) |
| 150 | Kawasaki syndrome | 45.2 | 934 | Citations (PDF) |
| 151 | CHARACTERIZATION OF A WHITE BASS (MORONE CHRYSOPS) EMBRYONIC CELL LINE WITH EPITHELIAL FEATURES | 1.1 | 14 | Citations (PDF) |
| 152 | Pharmacokinetic and Tolerability Assessment of a Pediatric Oral Formulation of Pentoxifylline in Kawasaki Disease | 1.6 | 19 | Citations (PDF) |
| 153 | Recurrent Kawasaki Disease–like Syndrome in a Patient with Acquired Immunodeficiency Syndrome | 3.8 | 24 | Citations (PDF) |
| 154 | Rethinking the Boundaries of Kawasaki Disease: Toward a Revised Case Definition | 0.2 | 26 | Citations (PDF) |
| 155 | Sensorineural hearing loss and Kawasaki disease: A prospective study | 0.9 | 59 | Citations (PDF) |
| 156 | Reporter Gene Expression in Fish Following Cutaneous Infection with Pantropic Retroviral Vectors | 1.8 | 5 | Citations (PDF) |
| 157 | Increased Frequency of Alleles Associated with Elevated Tumor Necrosis Factor-α Levels in Children with Kawasaki Disease | 1.5 | 88 | Citations (PDF) |
| 158 | HEMOLYMPH ANALYSIS AND EVALUATION OF NEWLY FORMULATED MEDIA FOR CULTURE OF SHRIMP CELLS (PENAEUS STYLIROSTRIS) | 1.1 | 10 | Citations (PDF) |
| 159 | Infectious Hypodermal and Hematopoietic Necrosis Virus of Shrimp Is Related to Mosquito Brevidensoviruses | 1.6 | 130 | Citations (PDF) |
| 160 | Expression of foreign genes in primary cultured cells of the blue shrimp Penaeus stylirostris | 1.3 | 40 | Citations (PDF) |
| 161 | Abnormal myocardial mechanics in Kawasaki disease: Rapid response to γ-globulin | 1.8 | 69 | Citations (PDF) |
| 162 | Psoriatic eruption in Kawasaki disease | 1.7 | 73 | Citations (PDF) |
| 163 | INFECTION OF CULTURED EMBRYO CELLS OF THE PACIFIC OYSTER, CRASSOSTREA GIGAS, BY PANTROPIC RETROVIRAL VECTORS | 1.1 | 24 | Citations (PDF) |
| 164 | Abnormal myocardial mechanics in Kawasaki disease: Rapid response to [gamma ]-globulin | 1.8 | 71 | Citations (PDF) |
| 165 | Relationship of climate, ethnicity and socioeconomic status to Kawasaki disease in San Diego County, 1994 through 1998 | 0.8 | 86 | Citations (PDF) |
| 166 | INFECTION OF CULTURED EMBRYO CELLS OF THE PACIFIC OYSTER, CRASSOSTREA GIGAS, BY PANTROPIC RETROVIRAL VECTORS | 1.1 | 1 | Citations (PDF) |
| 167 | Pantropic retroviral vectors mediate gene transfer and expression in Entamoeba histolytica | 1.0 | 19 | Citations (PDF) |
| 168 | Infection of lepidoptera with a pseudotyped retroviral vector | 2.8 | 15 | Citations (PDF) |
| 169 | Transgenic cattle produced by reverse-transcribed gene transfer in oocytes | 5.3 | 160 | Citations (PDF) |
| 170 | Cerebrospinal fluid profile in patients with acute Kawasaki disease | 0.8 | 101 | Citations (PDF) |
| 171 | Intravenous gamma-globulin treatment and retreatment in Kawasaki disease | 0.8 | 413 | Citations (PDF) |
| 172 | A Moloney Murine Leukemia Virus-Based Retroviral Vector Pseudotyped by the Insect Retroviral
gypsy
Envelope Can Infect
Drosophila
Cells | 2.4 | 58 | Citations (PDF) |
| 173 | Clinical presentation of Kawasaki disease | 0.2 | 5 | Citations (PDF) |
| 174 | Passive surveillance for Kawasaki disease in San Diego County | 0.8 | 23 | Citations (PDF) |
| 175 | Sequelae of Kawasaki disease in adolescents and young adults | 0.7 | 326 | Citations (PDF) |
| 176 | Gastrointestinal hemorrhage complicating aspirin therapy in acute Kawasaki disease | 1.7 | 58 | Citations (PDF) |
| 177 | Production of transgenic dwarf surfclams, Mulinia lateralis, with pantropic retroviral vectors. | 5.3 | 64 | Citations (PDF) |
| 178 | Prospective Comparison of Culture vs Genome Detection for Diagnosis of Enteroviral Meningitis in Childhood | 3.8 | 39 | Citations (PDF) |
| 179 | Molecular identification of viruses in sudden infant death associated with myocarditis and pericarditis | 0.8 | 59 | Citations (PDF) |
| 180 | Conjunctival Biopsy in Patients with Kawasaki Disease | 1.0 | 17 | Citations (PDF) |
| 181 | Kawasaki disease | 4.9 | 2 | Citations (PDF) |
| 182 | Pantropic Retroviral Vector-Mediated Gene Transfer, Integration, and Expression in Cultured Newt Limb Cells | 1.3 | 50 | Citations (PDF) |
| 183 | Detection of novel RNA viruses: morbilliviruses as a model system | 1.8 | 11 | Citations (PDF) |
| 184 | Adenovirus myocarditis: Retrospective diagnosis by gene amplification from formalin-fixed, paraffin-embedded tissues | 1.7 | 54 | Citations (PDF) |
| 185 | SEROPREVALENCE OF HUMAN HERPESVIRUS 7 IN PATIENTS WITH KAWASAKI DISEASE | 0.8 | 11 | Citations (PDF) |
| 186 | Gamma globulin re-treatment in Kawasaki disease | 1.7 | 178 | Citations (PDF) |
| 187 | Canine pain syndrome: A model for Kawasaki disease | 0.2 | 0 | Citations (PDF) |
| 188 | Psoriatic rash in Kawasaki disease | 0.2 | 0 | Citations (PDF) |
| 189 | Effect of high doses of intravenously administered immune globulin on natural killer cell activity in peripheral blood | 1.7 | 51 | Citations (PDF) |
| 190 | Gamma globulin retreatment in Kawasaki disease | 0.2 | 4 | Citations (PDF) |
| 191 | Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease | 1.7 | 190 | Citations (PDF) |
| 192 | Decreased protein binding of salicylates in Kawasaki disease | 1.7 | 37 | Citations (PDF) |
| 193 | Canine Pain Syndrome Is a Model for the Study of Kawasaki Disease | 0.2 | 25 | Citations (PDF) |
| 194 | Characterization of the Polymerase Activity Associated with Cultured Peripheral Blood Mononuclear Cells from Patients with Kawasaki Disease | 1.5 | 8 | Citations (PDF) |
| 195 | Sensorineural hearing loss associated with kawasaki disease | 1.7 | 48 | Citations (PDF) |
| 196 | Kawasaki Disease and Cervical Adenopathy | 2.0 | 54 | Citations (PDF) |
| 197 | Kawasaki Syndrome | 0.7 | 22 | Citations (PDF) |
| 198 | Increased prevalence of atopic dermatitis in Kawasaki disease | 0.8 | 70 | Citations (PDF) |
| 199 | Increased prevalence of atopic dermatitis in Kawasaki disease | 0.8 | 1 | Citations (PDF) |
| 200 | Clinical spectrum of Kawasaki disease in infants younger than 6 months of age | 1.7 | 191 | Citations (PDF) |
| 201 | Kawasaki syndrome and house dust mite exposure | 0.8 | 19 | Citations (PDF) |
| 202 | Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease | 31.3 | 108 | Citations (PDF) |
| 203 | The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin | 19.4 | 1,436 | Citations (PDF) |
| 204 | Anterior uveitis associated with Kawasaki syndrome | 0.8 | 92 | Citations (PDF) |
| 205 | Treatment of Respiratory Viral Infection in an Immunodeficient Infant With Ribavirin Aerosol | 3.8 | 49 | Citations (PDF) |
| 206 | Transplacental passage of influenza A/Bangkok (H3N2) mimicking amniotic fluid infection syndrome | 2.2 | 83 | Citations (PDF) |
| 207 | Coagulopathy and platelet activation in Kawasaki syndrome: Identification of patients at high risk for development of coronary artery aneurysms | 1.7 | 141 | Citations (PDF) |
| 208 | Pancreatic islet cell necrosis: Association with hemolytic-uremic syndrome | 1.7 | 42 | Citations (PDF) |
| 209 | Pathology of the Coronary Arteries and Myocardium in Kawasaki Disease | 20.5 | 7 | Citations (PDF) |
| 210 | Cost-effectiveness analysis of second intravenous immunoglobulin infusion versus infliximab for treating IVIG-resistant Kawasaki disease patients | 1.4 | 1 | Citations (PDF) |
| 211 | Molecular characterization of Kawasaki disease subgroups using cell-free RNA profiling | 2.7 | 4 | Citations (PDF) |
| 212 | Kawasaki Disease and the Importance of Family History | 0.2 | 0 | Citations (PDF) |
| 213 | Minimal correlation but complementary diagnostic utility for plasma cell-free RNA and proteins | 3.6 | 0 | Citations (PDF) |
| 214 | Kawasaki Disease in Adults | 0.7 | 1 | Citations (PDF) |
| 215 | Glucocorticoids in Kawasaki Disease — Refining Indications and the Science | 19.4 | 1 | Citations (PDF) |
| 216 | Acute Intensification May Reduce Persistent Coronary Artery Damage from Kawasaki Disease in Infants Younger Than 6 Months | 1.7 | 0 | Citations (PDF) |
| 217 | Characterization of innate immune cells with regulatory functions in subjects with a remote history of Kawasaki disease who lack natural regulatory T cell specificities | 1.7 | 0 | Citations (PDF) |
| 218 | Chronic Total Occlusion After Kawasaki Disease | 0.2 | 0 | Citations (PDF) |
| 219 | Epidemiology of Kawasaki Disease by Age Group Suggests Different Triggers | 5.2 | 0 | Citations (PDF) |
| 220 | Multisystem Inflammatory Syndrome Therapies in Children: A Comparative Effectiveness Trial | 1.7 | 0 | Citations (PDF) |
